Evaluation of an Augmented Reality-Based Visual Aid for People with Peripheral Visual Field Loss

Augmented reality (AR) technologies can improve the quality of life of individuals with visual impairments. The current study evaluated the efficacy of Retiplus, a new AR-based low-vision device, which was designed to enhance spatial awareness and visual function in patients with peripheral visual field loss. Thirteen patients diagnosed with retinitis pigmentosa (RP) participated in this study. The patients’ visual acuity, visual field, and subjective perception of peripheral vision and mobility were assessed both without and with the AR aid, following a training period consisting of five 1 h sessions. The results showed a significant expansion of the visual field (VF) in all four quadrants (right, left, upper, and lower) with a greater horizontal diameter enlargement (21.38° ± 12.94°) than vertical (15° ± 10.08°), with a statistically significant difference. However, the increase in VF was accompanied by a modest reduction in visual acuity due to the minification of the image on the display. Patient feedback also highlighted significant benefits on the ability to perform activities of daily living (ADL) in low-light environments and improved spatial orientation, suggesting that the AR system is helpful for some limitations imposed by patients’ conditions. These findings underscore the importance of optimizing AR technology to support visually impaired populations.